The hemostatic system as a regulator of angiogenesis

Journal of Biological Chemistry

Volumn 275, Issue 3, 2000, Pages 1521-1524

  Browder, Timothy ^a,b   Folkman, Judah ^a,b   Pirie Shepherd, Steven ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANTITHROMBIN III; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; FIBRIN; HIGH MOLECULAR WEIGHT KININOGEN; PLASMINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PLATELET DERIVED GROWTH FACTOR; PROTHROMBIN; SCATTER FACTOR; SOMATOMEDIN B; SOMATOMEDIN C; SPHINGOSINE 1 PHOSPHATE; THROMBOCYTE FACTOR 4; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANGIOGENESIS; BLOOD CLOTTING; BLOOD VESSEL INJURY; FIBRIN DEPOSITION; FIBRINOLYSIS; HEMOSTASIS; HUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; SHORT SURVEY; THROMBOCYTE; VASCULAR ENDOTHELIUM;

ANIMALS; BLOOD PLATELETS; BLOOD VESSELS; CAPILLARIES; FIBRIN; FIBRINOLYSIS; HEMOSTASIS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET AGGREGATION;

EID: 0034695685     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.275.3.1521     Document Type: Short Survey

References (67)

1. Mohle, R., Green, D., Moore, M. A. S., Nachman, R. L. & Rafii, S. (1997) Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc. Natl. Acad. Sci. U. S. A. 94, 663-668
2. Wartiovaara, U., Salven, P., Mikkola, H., Lassila, R., Kaukonen, J., Joukov, V., Orpana, A., Ristimaki, A., Heikinheimo, M., Joensuu, H., Aitalo, K. & Palotie, A. (1998) Peripheral blood platelets express VEGF-C and VEGF which are released during platelet activation. Thromb. Haemostasis 80, 171-175
3. Brunner, G., Nguyen, H., Gabrilove, J., Rifkin, D. B. & Wilson, E. L. (1993) Basic fibroblast growth factor expression in human bone marrow and peripheral blood cells. Blood 81, 631-638
4. Nakamura, T., Teramoto, H. & Ichihara, A. (1986) Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary culture. Proc. Natl. Acad. Sci. U. S. A. 83, 6489-6493
5. Hiraoka, N., Allen, E., Apel, I. J., Gyetko, M. R. & Weiss, S. J. (1988) Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95, 365-377
6. Karey, K. P., Marquardt, H. & Sirbasku, D. A. (1989) Human platelet-derived mitogens. I. Identification of insulin-like growth factors I and II by purification and N-terminal amino acid sequence analysis. Blood 74, 1084-1092
7. Karey, K. P. & Sirbasku, D. A. (1989) Human platelet-derived mitogens. II. Subcellular localization of insulin-like growth factor I to the alpha granule and release in response to thrombin. Blood 74, 1093-1100
8. Ben-Ezra, J., Sheibani, K., Hwabg, D. L. & Lev-Ran, A. (1990) Megakaryocyte synthesis is the source of epidermal growth factor in human platelets. Am. J. Pathol. 137, 755-759
9. Hwang, D. L., Lev-Ran, A., Yen, C. F. & Sniecinski, I. (1992) Release of different fractions of epidermal growth factor from human platelets in vitro: preferential release of 140 kDa fraction. Regul. Pept. 37, 95-100
10. Bar, R. S., Boes, M., Booth, B. A., Dake, B. L., Henley, S. & Hart, M. N. (1989) The effects of platelet-derived growth factor in cultured microvessel endothelial cells. Endocrinology 124, 1841-1848
11. Heldin, C.-H., Westermark, B. & Wasteson, A. (1981) Platelet-derived growth factor: isolation by a large-scale procedure and analysis of subunit composition. Biochem. J. 193, 907-913
12. Lee, O.-H., Kim, Y.-M., Lee, Y. M., Moon, E.-J., Lee, D.-J., Kim, J.-H., Kim, K.-W. & Kwon, Y.-G. (1999) Sphingosine 1-phosphate induces angiogenesis: its angiogenic action and signaling mechanism in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 264, 743-750
13. Shima, N., Itagaki, Y., Nagao, M., Yasuda, H., Morinaga, T. & Higashio, K. (1991) A fibroblast-derived tumor cytotoxic factor/F-TCF (hepatocyte growth factor/HGF) has multiple functions in vitro. Cell Biol. Int. Rep. 15, 397-408
14. Rosen, E. M., Lamszus, K., Laterra, J., Polverini, P. J., Rubin, J. S. & Goldberg, I. D. (1997) in Plasminogen-related Growth Factors (Gherardi, E., ed) pp. 215-226, John Wiley & Sons, Chichester, United Kingdom
15. Date, K., Matsumoto, K., Kubs, K., Shimura, H., Tanaka, M. & Nakamura, T. (1998) Inhibition of tumor growth and invasion by a four-kringle antagonist (HGF/NK4) for hepatocyte growth factor. Oncogene 17, 3045-3054
16. Holmgren, L., O'Reilly, M. S. & Folkman, J. (1995) Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat. Med. 1, 149-153
17. Taylor, S. & Folkman, J. (1982) Protamine is an inhibitor of angiogenesis. Nature 297, 307-312
18. Maione, T. E., Gray, G. S., Petro, J., Hunt, A. J., Donner, A. L., Bauer, S. I., Carson, H. F. & Sharpe, R. J. (1990) Inhibition of angiogenesis by recombinant human platelets factor-4 and related peptides. Science 247, 77-79
19. Perollet, C., Han, Z. C., Savona, C., Caen, J. P. & Bikfalvi, A. (1998) Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Blood 91, 3289-3299
20. Gengrinovitch, S., Greenberg, S. M., Cohen, T., Gitay-Goren, H., Rockwell, P., Maione, T. E., Levi, B.-Z. & Neufeld, G. (1995) Platelet factor-4 inhibits the mitogenic activity of VEGF-121 and VEGF-165 using several concurrent mechanisms. J. Biol. Chem. 270, 15059-15065
21. Maione, T. E., Gray, G. S., Hunt, A. J. & Sharpe, R. J. (1991) Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res. 51, 2077-2083
22. Jaffe, E., Leung, L. L. K., Nachman, R. L., Levin, R. L. & Mosher, D. F. (1982) Thrombospondin is the endogenous lectin of human platelets. Nature 295, 246-248
23. Rabbi-Sabile, S., Thibert, V. & Legrand, C. (1996) Thrombospondin peptides inhibit the secretion-dependent phase of platelet aggregation. Blood Coagul. Fibrinolysis 7, 237-240
24. Schultz-Cherry, S., Ribeiro, S., Gentry, L. & Murphy-Ullrich, J. E. (1994) Thrombospondin binds and activates the small and large forms of latent transforming growth factor-beta in a chemically defined system. J. Biol. Chem. 269, 26775-26782
25. Panetti, T. S., Kudryk, B. J. & Mosher, D. F. (1999) Interaction of recombinant procollagen and properdin modules of thrombospondin-1 with heparin and fibrinogen/fibrin. J. Biol. Chem. 274, 430-437
26. Iruela-Arispe, M. L., Liska, D. J., Sage, E. H. & Bornstein, P. (1993) Differential expression of thrombospondin 1, 2, and 3 during murine development. Dev. Dyn. 197, 40-56
27. Adams, J. C. (1997) Thrombospondin-1. Int. J. Biochem. Cell Biol. 29, 861-865
28. Good, D. J., Polverini, P. J., Rastinejad, F., Beau, M. M. L., Lemons, R. S., Frazier, W. A. & Bouck, N. P. (1990) A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc. Natl. Acad. Sci. U. S. A. 87, 6624-6628
29. Assoain, R. K., Komoriya, A., Meyers, C. A., Miller, D. M. & Sporn, M. B. (1983) Transforming growth factor-beta in human platelets. J. Biol. Chem. 258, 7155-7160
30. Roberts, A. B. & Sporn, M. B. (1989) Regulation of endothelial cell growth, architecture, and matrix synthesis by TGF-beta. Am. Rev. Respir. Dis. 140, 1126-1128
31. Hill, S. A., Shaughnessy, S. G., Joshua, P., Ribau, J., Austin, R. C. & Podor, T. J. (1996) Differential mechanisms targeting type I plasminogen activator inhibitor and vitronectin into the storage granules of a human megakaryocytic cell line. Blood 87, 5061-5073
32. Blei, F., Wilson, E. L., Mignatti, P. & Rifkin, D. B. (1993) Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J. Cell. Physiol. 155, 568-578
33. Collen, A., Koolwijk, P., Kroon, M. & von Hinsbergh, V. W. M. (1998) Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells. Angiogenesis 2, 153-165
34. Kroon, M. E., Koolwijk, P., van Goor, H., Weidle, U. H., Collen, A., van der Pluijm, G. & von Hinsbergh, V. W. M. (1999) Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices. Am. J. Pathol. 154, 1731-1742
35. Plow, E. F. & Collen, D. (1981) The presence and release of alpha2-antiplasmin from human platelets. Blood 58, 1069-1074
36. Nachman, R. L. & Harpel, P. C. (1976) Platelet alpha2-macroglobulin and alphal-antitrypsin. J. Biol. Chem. 251, 4512-4521
37. Fukao, H., Ueshima, S., Okada, K. & Matsuo, O. (1997) The role of the pericellular fibrinolytic system in angiogenesis. Jpn. J. Physiol. 47, 161-171
38. Colman, R. W., Lin, Y., Johnson, D. & Mousa, S. A. (1998) Inhibition of angiogenesis by peptides derived from kininogen. Blood 92, (suppl.) 174 (abstr.)
39. Rhim, T. Y., Park, C.-S., Kim, E. & Kim, S. S. (1998) Human prothrombin fragment 1 and 2 inhibit bFGF-induced BCE cell growth. Biochem. Biophys. Res. Commun. 252, 513-516
40. Tsopanoglou, N. E., Pipili-Synetos, E. & Maragoudakis, M. E. (1993) Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Am. J. Physiol. 264, C1302-C1307
41. O'Reilly, M. S., Pirie-Shepherd, S., Lane, W. S. & Folkman, J. (1999) Antiangiogenic activity of the cleaved conformation of the Serpin antithrombin. Science 285, 1926-1931
42. Sahni, A., Odrljin, T. & Francis, C. W. (1998) Binding of basic fibroblast growth factor to fibrinogen and fibrin. J. Biol. Chem. 273, 7554-7559
43. Kadish, J. L., Butterfield, C. E. & Folkman, J. (1979) The effect of fibrin on cultured vascular endothelial cells. Tissue Cell 11, 99-108
44. Thiagarajan, P., Rippon, A. J. & Farrell, D. H. (1996) Alternative adhesion sites in human fibrinogen for vascular endothelial cells. Biochemistry 35, 4169-4175
45. Vailhe, B., Ronot, X., Traque, P., Usson, Y. & Tranqup, L. (1997) In vitro angiogenesis is modulated by the mechanical properties of fibrin gels and is related to alpha-v/beta-3 integrin localization. In Vitro Cell. Dev. Biol. 33, 763-773
46. Bach, T. L., Barsigian, C., Chalupowicz, D. G., Busler, D., Yaen, C. H., Grant, D. S. & Martinez, J. (1998) VE-Cadherin mediates endothelial cell capillary tube formation in fibrin and collagen gels. Exp. Cell Res. 238, 324-334
47. Harrison, P. & Cramer, E. M. (1993) Platelet alpha-granules. Blood Rev. 7, 52-62
48. Henke, C. A., Roongta, U., Mickelson, D. J., Knutson, J. R. & McCarthy, J. B. (1996) CD44-related chondroitin sulfate proteoglycan, a cell surface receptor implicated with tumor cell invasion, mediates endothelial cell migration on fibrinogen and invasion into a fibrin matrix. J. Clin. Invest. 97, 2541-2552
49. Collen, D., Linden, H. R. & Verstraete, M. (1995) in Blood: Principles and Practice of Hematology (Handin, R. I., IV, Samuel, E., Lux, I., and Stossel, T. P., eds) pp. 1261-1288, J. B. Lippincott Co., Philadelphia
50. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H. & Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328
51. O'Reilly, M. S., Holmgren, L., Chen, C. & Folkman, J. (1996) Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med. 2, 689-692
52. Cao, Y., Ji, R. W., Davidson, D., Schaller, J., Marti, D., Sohndel, S., McCance, S. G., O'Reilly, M. S., Llinas, M. & Folkman, J. (1996) Kringle domains of angiostatin: characterization of the anti-proliferative activity on endothelial cells. J. Biol. Chem. 271, 29461-29467
53. Cao, Y., Chen, A., An, S. S. A., Ji, R. W., Davidson, D. & Llinas, M. (1997) Kringle 5 of plasminogen is a novel inhibitor of endothelial cell growth. J. Biol. Chem. 272, 22924-22928
54. Moser, T. L., Stack, M. S., Asplin, J., Enghild, J. J., Hojrup, P., Everitt, L., Hubchak, S., Schnaper, H. W. & Pizzo, S. V. (1999) Angiostatin binds ATP synthase on the surface of human endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 96, 2811-2816
55. O'Reilly, M. S., Wiederschain, D., Stetler-Stevenson, W. G., Folkman, J. & Moses, M. A. (1999) Regulation of angiostatin production by matrix metalloproteinase-2 in a model of concomitant resistance. J. Biol. Chem. 274, 29568-29571
56. Lijnen, H. R., Ugwu, F., Bini, A. & Collen, D. (1998) Generation of angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3). Biochemistry 37, 4699-4702
57. Patterson, B. C. & Sang, Q. A. (1997) Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J. Biol. Chem. 272, 28823-28825
58. Stathakis, P., Fitzgerald, M., Matthias, L. J., Chestermna, C. N. & Hogg, P. J. (1997) Generation of angiostatin by reduction and proteolysis of plasmin: catalysis by a plasmin reductase secreted by cultured cells. J. Biol. Chem. 272, 20641-20645
59. Stathakis, P., Lay, A. J., Fitzgerald, M., Schlieker, C., Matthias, L. J., & Hogg, P. J. (1999) Angiostatin formation involves disulfide bond reduction and proteolysis in kringle 5 of plasmin. J. Biol. Chem. 274, 8910-8916
60. Dong, Z., Kumar, K., Yang, X. & Fidler, I. J. (1997) Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell 88, 801-810
61. Stack, M. S., Gately, S., Bafetti, L. M., Enghild, J. J. & Soff, G. A. (1999) Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation. Biochem. J. 340, 77-34
62. Lind, S. E. (1995) in Blood: Principles and Practice of Hematology (Handin, R. I., IV, Samuel, E., Lux, I., and Stossel, T. P.) pp. 949-972, J. B. Lippincott Co., Philadelphia
63. Kwak, H. J., So, J.-N., Lee, S. J., Kim, I. & Koh, G. Y. (1999) Angiopoietin-1 is an apoptosis survival factor for endothelial cells. FEBS Lett. 448, 249-253
64. Papapetropoulos, A., Garcia-Cardena, G., Dengler, T. J., Maisonpierre, P. C., Yancopoulos, G. D., & Sessa, W. C. (1999) Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab. Invest. 79, 213-223
65. Ucki, N., Nakazato, M., Ohkawa, T., Ikeda, T., Amuro, Y., Hada, T. & Higashino, K. (1992) Excessive production of transforming growth factor beta-1 can play an important role in the development of tumorigenesis by its action for angiogenesis: validity of neutralizing antibodies to block tumor growth. Biochim. Biophys. Acta 1137, 189-196
66. Bacharach, E., Itin, A. & Keshet, E. (1992) In vivo patterns of expression of urokinase and its inhibitor PAI-1 suggest a concerted role in regulating physiological angiogensis. Proc. Natl. Acad. Sci. U. S. A. 89, 10686-10690
67. Colman, R. W., Pixley, R. A., Najamunnisa, S., Yan, W., Wang, J., Mazar, A. & McCrae, K. R. (1997) Binding of high molecular weight kininogen to human endothelial cells is mediated via a site within domains 2 and 3 of the urokinase receptor. J. Clin. Invest. 100, 1481-1487